Belfast medtech Neurovalens bags £6m to scale global expansion

▤ Summary

Neurovalens raised £6 million to support its commercial expansion in global healthcare markets. The Belfast medtech company will use the capital to accelerate sales of its FDA-approved Modius Sleep and Modius Calm devices in the US. It also plans to advance its regulatory pipeline and extend its product portfolio with additional FDA approvals. The round included investment from the Investment Fund for Northern Ireland, Whiterocks Growth Capital Fund, and existing backers. The company says the funding will help it scale internationally and grow its current medical device sales.

$ Funding

▦ Linked Companies